Carlton Hofferkamp & Jenks Wealth Management, LLC Pfizer Inc Transaction History

Carlton Hofferkamp & Jenks Wealth Management, LLC

$307 Million
Q3 2024

A detailed history of Carlton Hofferkamp & Jenks Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Carlton Hofferkamp & Jenks Wealth Management, LLC holds 43,594 shares of PFE stock, worth $1.17 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

43,594

Previous 46,688 6.63%

Holding current value

$1.17 Million

Previous $1.31 Million 3.45%

% of portfolio

0.41%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $85,703 - $97,120	-3,094 Reduced 6.63%	43,594 $1.26 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $14,170 - $16,605	-561 Reduced 1.19%	46,688 $1.31 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $93,100 - $106,909	-3,596 Reduced 7.07%	47,249 $1.31 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $79,304 - $103,007	-3,035 Reduced 5.63%	50,845 $1.46 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $154,802 - $180,948	-4,824 Reduced 8.22%	53,880 $1.79 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $37,745 - $43,670	-1,045 Reduced 1.75%	58,704 $2.15 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $141,882 - $184,710	-3,602 Reduced 5.69%	59,749 $2.44 Million
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $99,072 - $129,328	-2,373 Reduced 3.61%	63,351 $3.25 Million
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $60,432 - $73,773	-1,381 Reduced 2.06%	65,724 $2.95 Million
Q2 2022 Jul 12, 2022	SELL	$46.53 - $55.17 $48,763 - $57,818	-1,048 Reduced 1.54%	67,105 $3.57 Million
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $50,279 - $62,302	-1,099 Reduced 1.59%	68,153 $3.76 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $78,838 - $116,865	-1,908 Reduced 2.68%	69,252 $3.64 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $14,130 - $18,151	-360 Reduced 0.5%	71,160 $3.44 Million
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $7,469 - $8,461	-208 Reduced 0.29%	71,520 $2.89 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $73,075 - $82,414	2,182 Added 3.14%	71,728 $2.76 Million
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $5,020 - $6,384	150 Added 0.22%	69,546 $2.55 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $67,976 - $79,752	2,141 Added 3.18%	69,396 $2.67 Million
Q2 2020 Jul 30, 2020	BUY	$30.12 - $36.54 $76,715 - $93,067	2,547 Added 3.94%	67,255 $2.64 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $75,738 - $108,213	2,802 Added 4.53%	64,708 $2.47 Million
Q4 2019 Jan 28, 2020	BUY	$32.92 - $37.36 $15,834 - $17,970	481 Added 0.78%	61,906 $2.49 Million
Q3 2019 Oct 11, 2019	BUY	$32.49 - $42.13 $27,811 - $36,063	856 Added 1.41%	61,425 $2.2 Million
Q2 2019 Jul 18, 2019	BUY	$36.98 - $41.52 $25,959 - $29,147	702 Added 1.17%	60,569 $2.59 Million
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $14,512 - $15,944	-387 Reduced 0.64%	59,867 $2.54 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $88,442 - $100,834	-2,299 Reduced 3.68%	60,254 $2.63 Million
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $5,825 - $7,065	-169 Reduced 0.27%	62,553 $2.76 Million
Q2 2018 Jul 06, 2018	SELL	$32.98 - $35.16 $26,416 - $28,163	-801 Reduced 1.26%	62,722 $2.28 Million
Q1 2018 Apr 18, 2018	SELL	$31.91 - $37.02 $39,057 - $45,312	-1,224 Reduced 1.89%	63,523 $2.24 Million
Q4 2017 Jan 26, 2018	BUY	$33.26 - $35.29 $6,918 - $7,340	208 Added 0.32%	64,747 $2.35 Million
Q3 2017 Oct 06, 2017	BUY	$31.0 - $34.15 $2 Million - $2.2 Million	64,539	64,539 $2.3 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlton Hofferkamp & Jenks Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carlton Hofferkamp & Jenks Wealth Management, LLC with notifications on news.

Account

Carlton Hofferkamp & Jenks Wealth Management, LLC Pfizer Inc Transaction History